Vista Pharmaceuticals announced its 34th Annual General Meeting (AGM) will be held virtually via Video Conferencing. Shareholders can attend and vote electronically, with a remote e-voting facility active for several days before the meeting. The company's register of members and share transfer books will be closed for the AGM. The Annual Report for FY 2024-25 and AGM Notice have been dispatched to shareholders and are available online. This ensures all investors can participate and transact business virtually, aligning with current virtual meeting norms.